| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,293 | 10,617 | 8,624 | 12,493 | | Cost of Revenue | 3,251 | 2,555 | 2,597 | 2,934 | | | Gross Profit | 17,042 | 8,062 | 6,027 | 9,559 | | | Operating Expenses | | Research Development | 1,846 | 1,205 | 1,537 | 1,749 | | Selling General and Administrative | 8,412 | 7,191 | 7,383 | 6,663 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,784 | (334) | (2,893) | 1,147 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 69 | 68 | 91 | | Earnings Before Interest And Taxes | 6,737 | (265) | (2,825) | 1,238 | | Interest Expense | (19) | 12 | 7 |
-
| | Income Before Tax | 6,756 | (277) | (2,832) | 1,238 | | Income Tax Expense | 301 | 37 | 29 | 41 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,455 | (314) | (2,861) | 1,197 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,455 | (314) | (2,861) | 1,197 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,455 | ($314) | ($2,861) | $1,197 |
|
0.10% Nasdaq 0.00%
Income Statement
